ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 23 Mar 2009
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
78495162 filed on 06th Oct 2004
Registration Number
N/A
Correspondent Address
Nadine P. Flynn
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ORSUMDA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
Mark Details
Serial Number
No 78495162
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Mar 2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 23rd Mar 2009 | ABANDONMENT - NO USE STATEMENT FILED |
| 25th Jul 2008 | EXTENSION 5 FILED |
| 25th Jul 2008 | TEAS EXTENSION RECEIVED |
| 25th Jul 2008 | EXTENSION 5 GRANTED |
| 07th Dec 2007 | EXTENSION 4 GRANTED |
| 07th Dec 2007 | EXTENSION 4 FILED |
| 07th Dec 2007 | TEAS EXTENSION RECEIVED |
| 16th Jul 2007 | TEAS EXTENSION RECEIVED |
| 16th Jul 2007 | EXTENSION 3 GRANTED |